6 new stocks added last week by ProPicks AI are already up by 2.5%. Don't miss the momentum!Get 50% off

Orbimed Advisors reduced stake in Oric Pharmaceuticals, Inc.

Published 04/01/2021, 05:27 PM
Updated 04/01/2021, 05:30 PM
© Reuters.  Orbimed Advisors reduced stake in Oric Pharmaceuticals, Inc.

On the 29th of March, Orbimed Advisors sold 103 thousand Oric Pharmaceuticals, Inc. (ORIC) shares for $2.4 million at an average price of $23.48 per share. Shares of Oric Pharmaceuticals, Inc. are up 19.31% since the transaction.

Orbimed Advisors's holding in Oric Pharmaceuticals, Inc. decreased to about 2.2 million shares with the transaction.

Orbimed Advisors first bought Oric Pharmaceuticals, Inc. stock in the second quarter of 2020. Orbimed Advisors also owns Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT), Biogen Inc (NASDAQ:BIIB), Eledon Pharmaceuticals, Inc. (ELDN) and Neurocrine Biosciences Inc (NASDAQ:NBIX). Oric Pharmaceuticals, Inc. is its number twenty one position by number of shares and market value among pharmaceuticals stocks.

Contrary to Orbimed Advisors, Alkeon Capital Management, California State Teachers Retirement System, and Citigroup (NYSE:C) added to ORIC shares.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.